Dietary Supplement
HMO
HMO is a dietary supplement with 3 clinical trials. Historical success rate of 66.7%.
Total Trials
3
Max Phase
—
Type
DIETARY SUPPLEMENT
Molecule
—
Success Metrics
Clinical Success Rate
66.7%
Based on 2 completed trials
Completion Rate
67%(2/3)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
1(33%)
Phase Distribution
Ph not_applicable
3
100%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
66.7%
2 of 3 finished
Non-Completion Rate
33.3%
1 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Completed(2)
Terminated(1)
Detailed Status
Completed2
Terminated1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
66.7%
Most Advanced
N/A
Trials by Phase
N/A3 (100.0%)
Trials by Status
completed267%
terminated133%
Recent Activity
0 active trials
Showing 3 of 3
terminatednot_applicable
Human Milk Oligosaccharide (HMO) Supplementation in Colic Management
NCT05554991
completednot_applicable
Effects of HMOs on the Faecal Microbiota and on Host Metabolism in Obese Children
NCT02786160
completednot_applicable
The Effects Of HMO On The Faecal Microbiota And On Gastrointestinal Symptoms In Healthy Volunteers
NCT01927900
Clinical Trials (3)
Showing 3 of 3 trials
NCT05554991Not Applicable
Human Milk Oligosaccharide (HMO) Supplementation in Colic Management
NCT02786160Not Applicable
Effects of HMOs on the Faecal Microbiota and on Host Metabolism in Obese Children
NCT01927900Not Applicable
The Effects Of HMO On The Faecal Microbiota And On Gastrointestinal Symptoms In Healthy Volunteers
All 3 trials loaded
Drug Details
- Intervention Type
- DIETARY SUPPLEMENT
- Total Trials
- 3